UB Paderborn / Katalog / Suche / in CDI

Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation

Annals of oncology, 2012-02, Vol.23 (2), p.427-435

2012

Volltextzugriff (PDF)

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

Breast cancer research and treatment, 2011-07, Vol.128 (2), p.447-456

2011

Volltextzugriff (PDF)

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

Cancer chemotherapy and pharmacology, 2013-01, Vol.71 (1), p.245-255

2013

Volltextzugriff (PDF)

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)

Annals of oncology, 2013-04, Vol.24 (4), p.1011-1017

2013

Volltextzugriff (PDF)

Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab

The pharmacogenomics journal, 2012-12, Vol.12 (6), p.468-475

2012

Volltextzugriff (PDF)

Prognostic utility of angiogenesis and hypoxia effectors in patients with operable squamous cell cancer of the larynx

Oral oncology, 2012-08, Vol.48 (8), p.709-716

2012

Volltextzugriff (PDF)

The impact of oxaliplatin-based chemotherapy for colorectal cancer on the autonomous nervous system

European journal of neurology, 2014-12, Vol.21 (12), p.1471-1477

2014

Volltextzugriff (PDF)

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial

Cancer chemotherapy and pharmacology, 2012-02, Vol.69 (2), p.533-546

2012

Volltextzugriff (PDF)

Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)

Annals of oncology, 2011-04, Vol.22 (4), p.827-834

2011

Volltextzugriff (PDF)

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer

British journal of cancer, 2010-09, Vol.103 (7), p.1048-1056

2010

Volltextzugriff (PDF)

Fifteen-year trends in metastatic breast cancer survival in Greece

Breast cancer research and treatment, 2010-02, Vol.119 (3), p.621-631

2010

Volltextzugriff (PDF)

P094 A Phase II study to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of BI 1291583 in patients with cystic fibrosis bronchiectasis (the Clairafly™ study)

Journal of cystic fibrosis, 2023-06, Vol.22, p.S92-S92

2023

Volltextzugriff (PDF)

Plasmonic Coupling in Silver Nanoparticle Aggregates and Their Polymer Composite Films for Near-Infrared Photothermal Biofilm Eradication

ACS applied nano materials, 2021-05, Vol.4 (5), p.5330-5339

2021

Volltextzugriff (PDF)

Evaluation of current prognostic and predictive markers in breast cancer: a validation study of tissue microarrays

Anticancer research, 2013-05, Vol.33 (5), p.2139-2145

2013

Volltextzugriff (PDF)

Dose-Dense Sequential Adjuvant Chemotherapy With Epirubicin, Paclitaxel and CMF Versus Epirubicin, Cmf and Weekly Docetaxel or Paclitaxel Followed by Trastuzumab for One Year in Patients With Early Breast Cancer

Annals of oncology, 2012-09, Vol.23, p.ix95

2012

Volltextzugriff (PDF)

Prediction of clinical outcome in patients with primary laryngeal carcinoma using gene expression profiling

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.5505-5505

2011

Volltextzugriff (PDF)

Prognostic value of immunophenotypic classification of breast cancer in high-risk patients treated with dose-dense sequential adjuvant chemotherapy

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e21110-e21110

2011

Volltextzugriff (PDF)

Abstract P1-07-15: Revisiting chromosome 17q copy number aberrations in early high-risk breast cancer

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P1-P1-07-15

2012

Volltextzugriff (PDF)

An RNA pseudoknot mediates toxin translation and antitoxin inhibition

Proceedings of the National Academy of Sciences - PNAS, 2024-07, Vol.121 (27), p.e2403063121

2024

Volltextzugriff (PDF)

Volumetric and MGMT parameters in glioblastoma patients: survival analysis

BMC cancer, 2012-01, Vol.12 (1), p.3-3, Article 3

2012

Volltextzugriff (PDF)

Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer

PloS one, 2013-08, Vol.8 (8), p.e70429-e70429

2013

Volltextzugriff (PDF)

Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study

Annals of the rheumatic diseases, 2019-06, Vol.78 (6), p.754-760

2019

Volltextzugriff (PDF)

A randomized phase I study of the safety and pharmacokinetics of BI 1291583 in healthy Japanese male subjects

British journal of clinical pharmacology, 2024-09

2024

Volltextzugriff (PDF)

A taxonomically representative strain collection to explore xenobiotic and secondary metabolism in bacteria

PloS one, 2022-07, Vol.17 (7), p.e0271125-e0271125

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)

Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab

Prognostic utility of angiogenesis and hypoxia effectors in patients with operable squamous cell cancer of the larynx

The impact of oxaliplatin-based chemotherapy for colorectal cancer on the autonomous nervous system

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial

Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer

Fifteen-year trends in metastatic breast cancer survival in Greece

P094 A Phase II study to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of BI 1291583 in patients with cystic fibrosis bronchiectasis (the Clairafly™ study)

Plasmonic Coupling in Silver Nanoparticle Aggregates and Their Polymer Composite Films for Near-Infrared Photothermal Biofilm Eradication

Evaluation of current prognostic and predictive markers in breast cancer: a validation study of tissue microarrays

Dose-Dense Sequential Adjuvant Chemotherapy With Epirubicin, Paclitaxel and CMF Versus Epirubicin, Cmf and Weekly Docetaxel or Paclitaxel Followed by Trastuzumab for One Year in Patients With Early Breast Cancer

Prediction of clinical outcome in patients with primary laryngeal carcinoma using gene expression profiling

Prognostic value of immunophenotypic classification of breast cancer in high-risk patients treated with dose-dense sequential adjuvant chemotherapy

Abstract P1-07-15: Revisiting chromosome 17q copy number aberrations in early high-risk breast cancer

An RNA pseudoknot mediates toxin translation and antitoxin inhibition

Volumetric and MGMT parameters in glioblastoma patients: survival analysis

Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis

Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study

A randomized phase I study of the safety and pharmacokinetics of BI 1291583 in healthy Japanese male subjects

A taxonomically representative strain collection to explore xenobiotic and secondary metabolism in bacteria

Suchergebnisse filtern